Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 63 for alzheimer

Edit search filters
  1. A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

    Jacksonville, FL

  2. A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

    Scottsdale/Phoenix, AZ

  3. A Safety, Methodological and Exploratory Biomarkers Study to Slow Disease Progression

    Jacksonville, FL

  4. Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

    Jacksonville, FL, Rochester, MN

  5. The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

    Jacksonville, FL, Rochester, MN

  6. A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease

    Jacksonville, FL

  7. The Cognitive Effects of Lorazepam in Healthy Older Individuals with TOMM40 Variable-length Polymorphisms

    Scottsdale/Phoenix, AZ

  8. A Study Evaluating the Use of 48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer’s Disease

    Jacksonville, FL

  9. DaTSCAN Imaging in Aging and Neurodegenerative Disease

    Rochester, MN, Jacksonville, FL

  10. A Study to Evaluate Compensatory Training to Support Everyday Function and Adherence to Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer